Review 1: "Durable SARS-CoV-2 B cell immunity after mild or severe disease"
This study investigates B cell responses in COVID-19 patients and finds infection elicits S protein RBD-specific memory B cells in most participants. Reviewers deem the study reliable, but find some claims overreaching citing lack of functional data.
Created on
Jan 20, 2021
Published on
Jan 20, 2021
Cite As
Wilmore, J. (2021). Review 1: “Durable SARS-CoV-2 B cell immunity after mild or severe disease.” Rapid Reviews Infectious Diseases. https://doi.org/10.1162/2e3983f5.70b83041